14+ hour, 45+ min ago  (265+ words) The trial is studying ateganosine followed by cemiplimab in NSCLC patients resistant to checkpoint inhibitors and chemotherapy. MAIA Biotechnology has activated a new US site, the Winship Cancer Institute of Emory University, and opened patient enrolment for the Phase II…...

10+ hour, 36+ min ago  (596+ words) The legislation aims to accelerate clinical trials, with a feedback date set for 30 June. A draft legislation aimed at accelerating drug discovery and clinical trials has been proposed in the US. Democratic Congressman Jake Auchincloss, the representative for Massachusetts" 4th congressional…...

11+ hour, 18+ min ago  (324+ words) Clinical Trials Arena Uveitis is the leading cause of preventable blindness in adults aged 2060 years, and while some details are known about how this develops, new information is emerging that may change the epidemiology of this disease. Uveitis, a condition…...

14+ hour, 57+ min ago  (394+ words) Global Data says that the industry has "absorbed significant disruption, with high M&A levels testament to recovery. Biopharma executives" confidence in the industry has reached its highest point in four years, reflecting a successful navigation through a largely disrupted…...

15+ hour, 36+ min ago  (333+ words) The randomised global study achieved its primary endpoint. Shionogi and F2 G have reported positive top line data from the global OASIS Phase III study evaluating oral antifungal drug olorofim, compared with Am Bisome followed by standard of care (SOC) in…...

1+ day, 7+ hour ago  (230+ words) Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance. In recent years, wearable devices that track sleep, activity, heart rate, and recovery through smartwatches, fitness bands, and rings have been increasingly used by millions…...

2+ day, 10+ hour ago  (417+ words) Clinical Trials Arena Sickle cell disease (SCD) is a genetic blood disorder that causes red blood cells to form in a crescent moon shape. These sickled blood cells can stick together and prevent oxygen from getting to a person's tissues…...

2+ day, 16+ hour ago  (238+ words) The study aims to enrol about 150 patients across multiple sites. The study aims to enrol 150 patients across multiple sites. Researchers will monitor adverse events, treatment persistence, and discontinuation rates throughout the duration of the study. The safety and effectiveness data…...

3+ day, 15+ hour ago  (324+ words) In both studies, oveporexton showed improvement at week 12 in daily functioning versus placebo across six FINI domains. Takeda has reported pivotal results from its Phase III First Light and Radiant Light studies of oveporexton (TAK-861), an oral orexin receptor 2 (OX2 R)-selective…...

3+ day, 13+ hour ago  (152+ words) Spli Sense is currently conducting a Phase IIb trial with its antisense oligonucleotide therapy. The Cystic Fibrosis Foundation has supplied $13m of funding to Spli Sense, helping the biotech continue development of its inhaled drug candidate designed to treat the disease....